Literature DB >> 17215656

Prevalence, treatment, and control of hypertension in primary care: gaps, trends, and opportunities.

Robert J Petrella1, Elizabeth P Merikle, Jared Jones.   

Abstract

Since most cases of hypertension are managed in family practice, estimates of the prevalence, treatment, and control in the primary care population are needed to adequately address the burden of hypertension in Canada as it has in other countries. The authors used a large primary care research database to determine the prevalence of hypertension between 2000 and 2003. Blood pressure recordings were used to estimate the rates of prevalence, treatment, and control of hypertension for the overall population and for important subgroups. The prevalence of hypertension was 17.3%, most patients had untreated hypertension (68.6%), and only 15.8% had blood pressure treated and controlled. Higher rates of treatment and control were observed among older adults, those with type II diabetes, and those with a previous myocardial infarction. Odds of achieving target blood pressure were significantly better when combination therapy vs monotherapy was used. The prevalence of hypertension in primary care is high and most patients remain untreated; however, increased risk appears to lead to better treatment and control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215656      PMCID: PMC8110140          DOI: 10.1111/j.1524-6175.2007.05944.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  41 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

2.  Control of hypertension--an important national priority.

Authors:  A V Chobanian
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

3.  Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program.

Authors:  Paul K Whelton; Jiang He; Lawrence J Appel; Jeffrey A Cutler; Stephen Havas; Theodore A Kotchen; Edward J Roccella; Ron Stout; Carlos Vallbona; Mary C Winston; Joanne Karimbakas
Journal:  JAMA       Date:  2002-10-16       Impact factor: 56.272

4.  Pharmacoutilization of antihypertensive drugs: a model of analysis.

Authors:  E Degli Esposti; A Sturani; L Degli Esposti; P L Macini; P Falasca; G Valpiani; S Buda
Journal:  Int J Clin Pharmacol Ther       Date:  2001-06       Impact factor: 1.366

5.  The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario.

Authors:  Karen Tu; Muhammad M Mamdani; Robert M Jacka; Natalie J Forde; Deanna M Rothwell; Jack V Tu
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

6.  Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995.

Authors:  H K Wolf; P Andreou; I R Bata; D G Comeau; R D Gregor; G Kephart; D R MacLean; I Sketris
Journal:  CMAJ       Date:  1999-09-21       Impact factor: 8.262

7.  Impact of a social marketing media campaign on public awareness of hypertension.

Authors:  Robert J Petrella; Mark Speechley; Peter W Kleinstiver; Terry Ruddy
Journal:  Am J Hypertens       Date:  2005-02       Impact factor: 2.689

8.  Hypertension control: how well are we doing?

Authors:  Ann M Borzecki; Ashley T Wong; Elaine C Hickey; Arlene S Ash; Dan R Berlowitz
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

9.  Burden of cardiovascular disease in Canada.

Authors:  Douglas G Manuel; Mark Leung; Kathy Nguyen; Peter Tanuseputro; Helen Johansen
Journal:  Can J Cardiol       Date:  2003-08       Impact factor: 5.223

10.  Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program.

Authors:  Norman R C Campbell; Finlay A McAlister; Rollin Brant; Mitch Levine; Denis Drouin; Ross Feldman; Robert Herman; Kelly Zarnke
Journal:  J Hypertens       Date:  2003-08       Impact factor: 4.844

View more
  13 in total

Review 1.  Isometric Handgrip as an Adjunct for Blood Pressure Control: a Primer for Clinicians.

Authors:  Cheri L McGowan; David N Proctor; Ian Swaine; Robert D Brook; Elizabeth A Jackson; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

2.  Physiologic tailoring of treatment in resistant hypertension.

Authors:  J David Spence
Journal:  Curr Cardiol Rev       Date:  2010-05

Review 3.  Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection.

Authors:  Domenico Galzerano; Cristina Capogrosso; Sara Di Michele; Emanuele Bobbio; Paola Paparello; Carlo Gaudio
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

4.  Symptoms and risk of obstructive sleep apnea in primary care patients in Jordan.

Authors:  Basheer Khassawneh; Mohammad Ghazzawi; Yousef Khader; Mousa Alomari; Zouhair Amarin; Bashar Shahrour; Mohanad Hammouda
Journal:  Sleep Breath       Date:  2008-12-10       Impact factor: 2.816

5.  A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.

Authors:  Matthew R Weir; Willa A Hsueh; Shawna D Nesbitt; Thomas J Littlejohn; Alan Graff; Ali Shojaee; William F Waverczak; Chunlin Qian; Christopher J Jones; Joel M Neutel
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-02-05       Impact factor: 3.738

6.  Efficacy of a family practice-based lifestyle intervention program to increase physical activity and reduce clinical and physiological markers of vascular health in patients with high normal blood pressure and/or high normal blood glucose (SNAC): study protocol for a randomized controlled trial.

Authors:  Robert J Petrella; Kuni Aizawa; Kevin Shoemaker; Tom Overend; Len Piche; Mauricio Marin; Sheree Shapiro; Sophie Atkin
Journal:  Trials       Date:  2011-02-16       Impact factor: 2.279

7.  An integrated approach to preventing cardiovascular disease: community-based approaches, health system initiatives, and public health policy.

Authors:  Tina Karwalajtys; Janusz Kaczorowski
Journal:  Risk Manag Healthc Policy       Date:  2010-09-06

8.  Frequency, Awareness, Treatment and Control of Hypertension in the over 40 Population of Erzincan.

Authors:  Rabia Hacihasanoglu; Tacettin Inandi; Arzu Yildirim; Papatya Karakurt; Rabia Saglam
Journal:  Turk Silahli Kuvvetleri Koruyucu Hekim Bul       Date:  2014

9.  Prevalence, Demographics, and Treatment Characteristics of Visual Impairment due to Diabetic Macular Edema in a Representative Canadian Cohort.

Authors:  Robert J Petrella; Julie Blouin; Brian Davies; Martin Barbeau
Journal:  J Ophthalmol       Date:  2012-12-11       Impact factor: 1.909

10.  Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort.

Authors:  Robert J Petrella; Julie Blouin; Brian Davies; Martin Barbeau
Journal:  J Ophthalmol       Date:  2012-10-14       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.